Clinical Report: HHS Dispatched Medication for Ebola Clinical Research Trial

Overview

The Department of Health and Human Services has sent doses of the monoclonal antibody MBP-134 for use in a clinical trial targeting Ebola treatment. This follows prior safety trials and is part of a response to the ongoing Ebola outbreak in the Democratic Republic of the Congo.

Background

Ebola virus disease (EVD) remains a significant public health threat, particularly in regions like the Democratic Republic of the Congo and Uganda. Recent advancements in monoclonal antibody therapies have been noted in the context of managing outbreaks.

Data Highlights

No specific numerical data was provided in the source material.

Key Findings

• The monoclonal antibody MBP-134 has been sent for use in a clinical trial for Ebola treatment.
• MBP-134 has previously undergone a Phase 1 safety trial.
• The World Health Organization is reviewing the trial protocol with ethics committees and regulatory authorities.
• As of the latest report, there have been 1,048 confirmed cases of Ebola in the DRC, with 267 deaths.
• HHS has coordinated shipments of investigational monoclonal antibodies for potential use in high-risk Americans exposed to Ebola.

Clinical Implications

The deployment of MBP-134 in clinical trials may provide data on its efficacy in treating Ebola.

Conclusion

The dispatch of MBP-134 is a step in addressing the current Ebola outbreak.

Related Resources & Content

1. Stat News, 2026 -- HHS confirms Americans with high-risk Ebola exposures will have access to experimental therapy
2. Stat News, 2026 -- Which vaccines will curb the Ebola outbreak? WHO debates
3. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics | New England Journal of Medicine
4. Clinical Guidance for Ebola Disease | Ebola | CDC
5. Intensive Care Medicine — Evaluation of Pre-hospital Transport Protocols for Ebola Patients in Western Nations: A Guideline Comparison
6. Associated Press Health — Trump admin awards hepatitis B vaccine contract to Europeans working in Guinea-Bissau
7. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics | New England Journal of Medicine
8. Ebola disease caused by Bundibugyo virus – Democratic Republic of the Congo
9. Clinical Guidance for Ebola Disease | Ebola | CDC